Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells

BACKGROUND: The molecular and cellular pathways driving the pathogenesis of severe asthma are poorly defined. Tumor progression locus 2 (TPL-2) (COT, MAP3K8) kinase activates the MEK1/2-extracellular-signal regulated kinase 1/2 MAP kinase signaling pathway following Toll-like receptor, TNFR1, and IL...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Allergy Clin Immunol
Asıl Yazarlar: Kannan, Yashaswini, Li, Yanda, Coomes, Stephanie M., Okoye, Isobel S., Pelly, Victoria S., Sriskantharajah, Srividya, Gückel, Eva, Webb, Lauren, Czieso, Stephanie, Nikolov, Nikolay, MacDonald, Andrew S., Ley, Steven C., Wilson, Mark S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mosby 2017
Konular:
Mechanisms of Allergy and Clinical Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292997/
https://ncbi.nlm.nih.gov/pubmed/27484038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.05.031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller